Insulin is a hormone produced by the pancreas that allows your cells to absorb glucose from the bloodstream and use it for energy. The word itself comes from the Latin “insula,” meaning island, because the hormone is made by clusters of cells in the pancreas called the islets of Langerhans. But insulin does far more than shuttle sugar into cells. It regulates fat storage, influences protein building, acts on the brain, and even affects how your blood vessels behave.
How Your Body Makes Insulin
Insulin is manufactured inside specialized cells called beta cells, which sit within the pancreatic islets. The process starts with a precursor molecule called preproinsulin. That gets trimmed down to proinsulin, which is then cut into two pieces: active insulin and a byproduct called C-peptide. Both are packaged into tiny storage bubbles (secretory granules) and held there until the body needs them.1PubMed Central. Regulation of insulin synthesis and secretion and pancreatic Beta-cell dysfunction in diabetes
The trigger for release is straightforward: rising blood glucose. After you eat, glucose levels climb, and beta cells sense this change. The glucose enters the beta cell, gets metabolized, and the resulting energy shifts the cell’s electrical charge. That electrical change opens calcium channels, and the rush of calcium tells the storage granules to fuse with the cell wall and dump their insulin into the bloodstream.2PubMed Central. Pancreatic β-Cell Electrical Activity and Insulin Secretion: Of Mice and Men The beta cell, in other words, acts as a built-in glucose sensor, constantly matching its insulin output to the concentration of sugar circulating in your blood.3PubMed Central. Glucose-sensing mechanisms in pancreatic beta-cells
Insulin doesn’t work alone. Its counterpart, glucagon, is secreted by neighboring alpha cells in the same pancreatic islets. While insulin lowers blood sugar, glucagon raises it by telling the liver to release stored glucose. The two hormones operate in a constant push-and-pull that keeps blood sugar within a narrow range.4PubMed Central. Pancreatic regulation of glucose homeostasis
How Insulin Gets Glucose Into Cells
Once insulin enters the bloodstream, it docks onto insulin receptors on the surfaces of your cells, particularly in muscle, fat, and liver tissue. That docking event kicks off a chain of signals inside the cell. A key early step involves a molecule called IRS-1, which acts as a relay, passing the insulin signal onward to several downstream partners.5PubMed. The IRS-1 signaling system
The end result of that signaling chain is the movement of glucose transporters, specifically a protein called GLUT4, from inside the cell up to the cell’s surface. Think of GLUT4 as a door for glucose. Normally it stays tucked away inside the cell. When insulin arrives, the signaling cascade moves those doors to the outer membrane, where they open and let glucose flow in.6PubMed Central. Insulin signalling and GLUT4 trafficking in insulin resistance Without insulin, those doors stay closed, and glucose piles up in the blood instead of entering the cells that need it.
Insulin’s Other Jobs
Blood sugar regulation gets the headlines, but insulin is involved in several other metabolic processes that are just as important for your health.
Controlling the Liver
Your liver constantly produces glucose, even when you haven’t eaten, through a process called gluconeogenesis. After a meal, when glucose is already flooding in from digestion, the liver needs to stop making more. Insulin is the signal that tells it to stand down. When insulin levels rise after eating, the liver dials back its glucose production, preventing blood sugar from climbing too high.7PubMed Central. Insulin regulation of gluconeogenesis
Managing Fat Storage
Insulin promotes fat storage and discourages fat breakdown. In fat cells, one of insulin’s basic roles is to inhibit lipolysis, the process of breaking stored fat (triglycerides) into free fatty acids for energy. When insulin is high, your body favors storing fat rather than burning it.8PubMed Central. Insulin inhibits lipolysis in adipocytes via the evolutionarily conserved mTORC1-Egr1-ATGL-mediated pathway This is why chronically elevated insulin levels are often discussed in the context of weight gain, though the relationship is more complex than simple cause and effect.
Building Protein
Insulin also stimulates protein synthesis in muscle tissue. It does this partly through a signaling pathway involving a protein complex called mTOR, which acts as a growth signal. In human skeletal muscle, insulin activates mTOR signaling when amino acids are available, helping drive the assembly of new proteins.9PubMed Central. Amino acids are necessary for the insulin-induced activation of mTOR/S6K1 signaling and protein synthesis in healthy and insulin resistant human skeletal muscle This is one reason nutrition advice for muscle building emphasizes not just protein intake but also adequate carbohydrate, since carbs drive insulin, and insulin helps direct those amino acids toward muscle repair.
Insulin in the Brain
For years, the brain was thought to be largely independent of insulin. That view has changed. Insulin crosses the blood-brain barrier, and there are insulin receptors scattered throughout the brain. There, it modulates appetite, body temperature, white fat mass, and even how the brain responds to low blood sugar. Insulin signaling in the brain also influences neurotransmitter activity, cholesterol production, and the health of mitochondria inside neurons. When brain insulin signaling is disrupted, it can impair nerve cell function and the formation of new connections between neurons.10PubMed Central. Insulin action in brain regulates systemic metabolism and brain function
Research increasingly connects brain insulin to mood and cognition. There is accumulating evidence that insulin in the central nervous system regulates behaviors like feeding, and may affect depression and cognitive performance.11PubMed Central. Insulin action in the brain regulates both central and peripheral functions This has sparked interest in whether impaired brain insulin signaling might contribute to neurodegenerative conditions, though that research is still in relatively early stages.
What Happens When Insulin Stops Working
When insulin’s system breaks down, blood sugar rises and stays high, a condition called hyperglycemia. The two most common forms of this breakdown are type 1 and type 2 diabetes, which involve very different underlying problems.
In type 1 diabetes, the immune system mistakenly attacks and destroys the beta cells that produce insulin. The result is an absolute or near-absolute lack of insulin, meaning the body simply cannot make enough of the hormone to function.12PubMed Central. The pathophysiology, presentation and classification of Type 1 diabetes People with type 1 diabetes need external insulin to survive.
Type 2 diabetes, which is far more common, involves a different problem: insulin resistance. The body still makes insulin, often more than normal, but the cells in muscle, liver, and fat tissue stop responding to it properly.13PubMed Central. Insulin Resistance: From Mechanisms to Therapeutic Strategies At a molecular level, this often shows up as reduced activity of the insulin receptor and weaker signaling through the pathways that normally move GLUT4 to the cell surface.14Signal Transduction and Targeted Therapy. Trends in insulin resistance: insights into mechanisms and therapeutic strategy
Obesity is one of the strongest drivers of insulin resistance. Excess fat, particularly around the organs, releases free fatty acids and inflammatory signals that actively interfere with insulin’s signaling cascade. Enlarged fat cells become oxygen-starved and trigger a state of chronic low-grade inflammation in the liver and pancreas, further disrupting the insulin pathway.15PubMed Central. Insulin resistance induced by obesity: Mechanisms, metabolic implications and therapeutic approaches The body compensates by producing more insulin, but eventually the beta cells can’t keep up, and blood sugar begins to rise.
How Doctors Measure Insulin Function
If you’ve had blood work related to diabetes risk, you may have heard of the HOMA-IR score. This is a formula that combines your fasting insulin level and fasting blood glucose to estimate how resistant your body is to insulin. A higher score suggests greater resistance. In one study, a HOMA-IR score of 2.8 or above was associated with obesity, and people with a BMI over 30 had roughly 17 times the odds of meeting that threshold compared to leaner individuals.16PubMed Central. Correlation between insulin-based and C-peptide based homeostatic model assessment of insulin resistance in adults without diabetes in a sub-Saharan African setting: a cross-sectional study
Remember the C-peptide that gets snipped off when proinsulin is converted to insulin? It turns out to be a useful clinical tool. Because C-peptide is released in equal amounts to insulin but is cleared from the blood more slowly, it can give doctors a steadier picture of how much insulin the pancreas is actually producing. In clinical comparisons, C-peptide-based assessments of insulin resistance have shown stronger correlations with components of metabolic syndrome than insulin-based measures alone.17PubMed. C-Peptide Is a Sensitive Indicator for the Diagnosis of Metabolic Syndrome in Subjects from Central Mexico This is especially relevant for people already taking insulin injections, since injected insulin makes blood insulin levels unreliable as a diagnostic marker, while C-peptide still reflects what the pancreas itself is doing.18PubMed Central. Biomarker potential of C-peptide for screening of insulin resistance in diabetic and non-diabetic individuals
Insulin Therapy and Modern Analogues
When the body can’t make enough insulin, or when resistance becomes severe enough that oral medications aren’t sufficient, insulin therapy fills the gap. The insulin used in injections today is no longer extracted from animal pancreases, as it was in the decades after insulin’s discovery. Modern insulin is produced using genetically engineered bacteria or yeast cells that manufacture human-identical insulin.
A major advance has been the development of insulin analogues, which are slightly modified versions of the insulin molecule designed to behave differently in the body. Some modifications produce rapid-acting insulins that kick in within minutes and wear off quickly, ideal for managing the blood sugar spike after a meal. Others produce long-acting insulins with a flatter, more drawn-out effect, providing a steady baseline level over many hours.19PubMed. Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety
Newer experimental approaches are pushing this further. Researchers have developed chemically modified insulin conjugates that not only last longer in the body but also have a wider safety margin, meaning the difference between an effective dose and a dose that would cause dangerously low blood sugar is much larger. One such approach using a modified form of long-acting insulin increased the maximum tolerated dose tenfold in preclinical testing.20PubMed Central. Di-PEGylated insulin: A long-acting insulin conjugate with superior safety in reducing hypoglycemic events That kind of improvement could reduce one of the biggest fears people on insulin face: accidentally injecting too much and experiencing a dangerous blood sugar crash.
Your Body Clock Sets Insulin Sensitivity
How well your cells respond to insulin isn’t constant throughout the day. Your body has internal clocks, both a central one in the brain and peripheral ones in tissues like the liver, pancreas, muscle, and fat. These clocks regulate when insulin is secreted, how sensitive tissues are to it, and even how quickly glucose is absorbed from the gut.21PubMed. Circadian clocks and insulin resistance
This isn’t just a theoretical framework. When researchers measured insulin signaling in human fat tissue around the clock, they found a robust circadian rhythm. Insulin sensitivity peaked around midday and was about 54% higher at noon than at midnight.22PubMed Central. Human adipose tissue expresses intrinsic circadian rhythm in insulin sensitivity The practical implication is intuitive if you think about it: your body handles carbohydrates better during the daytime than late at night. This is one biological reason behind the advice to avoid heavy meals close to bedtime, and it helps explain why shift workers, whose eating and sleeping schedules are chronically misaligned with their internal clocks, have elevated rates of metabolic problems.
Exercise and Insulin
Physical activity is one of the most powerful ways to improve how your body uses insulin, and the mechanisms are different from what insulin itself does. During exercise, your muscles pull glucose in through an insulin-independent pathway. They move GLUT4 transporters to the cell surface not because insulin told them to, but because the muscle is contracting and needs fuel. This glucose-lowering effect works even in people with type 2 diabetes, whose cells have become resistant to insulin’s signal.23Endocrine Reviews. Post-translational Modifications: The Signals at the Intersection of Exercise, Glucose Uptake, and Insulin Sensitivity
After exercise stops, a second benefit kicks in: the cells become more sensitive to insulin for up to 48 hours. During this window, insulin-stimulated glucose uptake is enhanced because prior exercise primes the internal pool of GLUT4, making it more responsive to insulin’s signal. Modeling studies in people with and without type 1 diabetes have estimated that a single exercise session can increase insulin-dependent glucose disposal by anywhere from about 10% to over 150%, depending on the individual and whether they have diabetes.24PubMed Central. Exercise effect on insulin-dependent and insulin-independent glucose utilization in healthy individuals and individuals with type 1 diabetes: a modeling study
Insulin and Your Blood Vessels
One of insulin’s less well-known roles is its effect on the cardiovascular system. Insulin stimulates the lining of blood vessels (the endothelium) to produce nitric oxide, a molecule that relaxes vessel walls and increases blood flow. This vasodilation helps direct more blood to skeletal muscle, which in turn helps muscle cells take up more glucose.25PubMed. Molecular and physiologic actions of insulin related to production of nitric oxide in vascular endothelium So insulin’s metabolic and vascular effects are intertwined: the hormone helps glucose get into cells both by opening the GLUT4 doors and by increasing the blood flow that delivers glucose to those cells in the first place.
This connection has implications for cardiovascular disease. In healthy people, endothelial nitric oxide production and insulin sensitivity are positively related.26PubMed. Endothelial nitric oxide production and insulin sensitivity. A physiological link with implications for pathogenesis of cardiovascular disease When insulin resistance develops, the signaling pathway that produces nitric oxide gets disrupted along with the glucose-handling pathway. The result is stiffer, less responsive blood vessels. This is one reason insulin resistance is considered a risk factor for heart disease and hypertension, not just for diabetes. The damage isn’t limited to blood sugar; it extends to the blood vessels themselves.
Insulin Across the Animal Kingdom
Insulin is not a human invention. The hormone is ancient, and versions of it appear across virtually all vertebrates and many invertebrates. Phylogenetic analysis shows that insulin, along with the closely related insulin-like growth factors IGF-1 and IGF-2, each form distinct evolutionary groups that trace back hundreds of millions of years. IGF-1 and IGF-2 appear to have arisen from the duplication of an ancestral gene, while insulin diverged to take on its specialized metabolic role.27Molecular Biology and Evolution. Evolution of Insulin, Insulin-like Growth Factors, and Their Cognate Receptors in Vertebrates, Invertebrates, and Viruses In insects, for example, insulin-like peptides regulate growth, metabolism, and lifespan. The deep conservation of this hormone across species underscores just how fundamental its role is in coordinating how organisms use energy. Every animal that eats and stores fuel has some version of the insulin problem to solve, and evolution landed on remarkably similar molecular tools to solve it.